Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Breast Neoplasms 5Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Vulvar Neoplasms 1Uterine Neoplasms 1Sentinel Lymph Node 1Rectal Neoplasms 1Node-positive Breast Cancer 1Neoplasm Micrometastasis 1Lymphatic Metastasis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Nivolumab 25pembrolizumab 20Ipilimumab 15toripalimab 12Temozolomide 11Biopsy 8Dacarbazine 7Cyclophosphamide 6Blood Specimen Collection 6trametinib 5fludarabine 5dabrafenib 5camrelizumab 5atezolizumab 5Gene Expression Profiling 5Chemotherapy, Adjuvant 5durvalumab 4binimetinib 4aldesleukin 4Interleukin-2 4Injections 4Carboplatin 4tislelizumab 3palbociclib 3encorafenib 3apatinib 3Sorafenib 3Paclitaxel 3Introns 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Melanoma × Sentinel Lymph Node Biopsy × Clear all
NCT02142244 2017-02-02

Fluorescence Surgery for Sentinel Node Identification in Melanoma

Barretos Cancer Hospital

Phase NA Unknown
318 enrolled
Dermatologic

Lymphatic Metastasis, Melanoma, Neoplasm Micrometastasis

NCT00897481 2013-08-12

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

National Cancer Institute (NCI)

Unknown
1,000 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡